Leyre Zubiri
11PUBLICATIONS
99CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jan 30, 2026
Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors.Nussara Pakvisal, Leontios Pappas, Bennett A Caughey
|May 16, 2025
Tumor location as a risk factor for severe immune-related adverse events.Steven M Blum, Ben Ouyang, Leyre Zubiri
|Sep 03, 2024
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records.Virginia H Sun, Julius C Heemelaar, Ibrahim Hadzic
|Apr 10, 2024
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.Steven T Chen, Yevgeniy R Semenov, Allireza Alloo
|Jun 15, 2022
Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study.Bruce C Tiu, Leyre Zubiri, James Iheke
|Mar 09, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19.Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch
Pageof 2
Frequent Collaborators
6 joint publications
Meghan J Mooradian
6 joint publications
Ryan Sullivan
6 joint publications
Kerry Reynolds
4 joint publications
Michael Dougan
3 joint publications
Jarushka Naidoo
3 joint publications
Steven M Blum
2 joint publications
Amanda C Guidon
2 joint publications
Allison Betof Warner
2 joint publications
Nicole R LeBoeuf
1 joint publications
Vivek Naranbhai
